http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2572380-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35655ff6b59f5aac079a582b42ccdf87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a60649a09a47690f2c5082c03fbc2212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47c16e709f3aa3db06160608956a7d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ac5f7768b4abe5bcb51d4a73c56e28f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y30-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073
filingDate 2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0173f3964e22c34d32428b4012d5e70d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91e0de8183dc945b5fee7eac48fb3d33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6b3689f87eb85a93447db0caea8a0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_805bc4654a9d74da4c383f074b5194cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3052b6bd64a8849eb7862eafc0bd108d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f2665a1e886e9eb49c29fcf9b7761a0
publicationDate 2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2572380-A1
titleOfInvention Gemcitabine derivatives nanoparticles
abstract The present invention relates to a derivative of 2 ', 2'-difluoro-2'-deoxycytidine of general formula (I): in which: R1, R2 and R3, which are identical or different, represent, independently of each other, a hydrogen atom or a hydrocarbon acyl radical at least C18 and conformation such it is capable of conferring on said compound of general formula (I) a form compacted in a polar solvent medium, at least one of the groups R 1 and R 2 and R3 being different from a hydrogen atom.
priorityDate 2004-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92034525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409028757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155

Total number of triples: 51.